---
figid: PMC3417062__nihms-396135-f0007
figlink: /pmc/articles/PMC3417062/figure/F7/
number: Fig. 7
caption: Model of molecular mechanisms underlying PA and histologically anaplastic
  PA. RAS/BRAF/MEK pathway activation by various mechanisms is a key feature of sporadic
  PA and NF1 PA. Histologically anaplastic PA develop in addition hyperactivation
  of the PI3K/PTEN/AKT pathway and inactivation of cell cycle inhibitors such as p16
  leading to increased proliferation
pmcid: PMC3417062
papertitle: PI3K/AKT pathway alterations are associated with clinically aggressive
  and histologically anaplastic subsets of pilocytic astrocytoma.
reftext: Erika F. Rodriguez, et al. Acta Neuropathol. ;121(3):407-420.
pmc_ranked_result_index: '36561'
pathway_score: 0.9710803
filename: nihms-396135-f0007.jpg
figtitle: Molecular mechanisms underlying PA and histologically anaplastic PA
year: ''
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3417062__nihms-396135-f0007.html
  '@type': Dataset
  description: Model of molecular mechanisms underlying PA and histologically anaplastic
    PA. RAS/BRAF/MEK pathway activation by various mechanisms is a key feature of
    sporadic PA and NF1 PA. Histologically anaplastic PA develop in addition hyperactivation
    of the PI3K/PTEN/AKT pathway and inactivation of cell cycle inhibitors such as
    p16 leading to increased proliferation
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAP2K2
  - EGFR
  - MAPK3
  - MAP2K1
  - MAPK1
  - CDKN2A
  - PIK3CA
  - AKT2
  - PIK3R6
  - PIK3CG
  - AKT1
  - PIK3CB
  - AKT3
  - PIK3CD
  - NF1
  - PTEN
  - PIK3R3
  - BRAF
  - RAF1
  - PIK3R4
  - PIK3R5
  - Cancer
  - Lung cancer
genes:
- word: MEK/ERK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: MEK/ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MEK/ERK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MEK/ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: p16
  symbol: p16
  source: hgnc_alias_symbol
  hgnc_symbol: CDKN2A
  entrez: '1029'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: -NF1
  symbol: NF1
  source: hgnc_symbol
  hgnc_symbol: NF1
  entrez: '4763'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: -BRAF
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: RAF1
  symbol: RAF1
  source: hgnc_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
---
